NDC 24689-119

BupropionHydrochlorideTablets

Bupropion Hydrochloride Tablets

BupropionHydrochlorideTablets is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Apnar Pharma Lp. The primary component is Bupropion Hydrochloride.

Product ID24689-119_d1830cfd-e7f5-345c-e053-2995a90a2251
NDC24689-119
Product TypeHuman Prescription Drug
Proprietary NameBupropionHydrochlorideTablets
Generic NameBupropion Hydrochloride Tablets
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-12-20
Marketing CategoryANDA /
Application NumberANDA075584
Labeler NameApnar Pharma LP
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength75 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 24689-119-01

100 TABLET, FILM COATED in 1 BOTTLE (24689-119-01)
Marketing Start Date2021-12-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "BupropionHydrochlorideTablets" or generic name "Bupropion Hydrochloride Tablets"

NDCBrand NameGeneric Name
24689-119BupropionHydrochlorideTabletsBupropion Hydrochloride Tablets
24689-120BupropionHydrochlorideTabletsBupropion Hydrochloride tablets

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.